Synergistic impact of endurance training and intermittent hypobaric hypoxia on cardiac function and mitochondrial energetic and signaling by Magalhães, J. et al.
  	

Synergistic impact of endurance training and intermittent hypobaric hypoxia
on cardiac function and mitochondrial energetic and signaling
Magalha˜es J, Falca˜o-Pires I, Gonc¸alves IO, Lumini-Oliveira J, Marques-
Aleixo I, dos Passos E, Rocha-Rodrigues S, Machado NG, Moreira AC,
Miranda-Silva D, Moura C, Leite-Moreira AF, Oliveira PJ, TorrellaJR.,
Ascensa˜o A
PII: S0167-5273(13)01526-X
DOI: doi: 10.1016/j.ijcard.2013.08.001
Reference: IJCA 16841
To appear in: International Journal of Cardiology
Received date: 3 June 2012
Revised date: 1 April 2013
Accepted date: 3 August 2013
Please cite this article as: J Magalha˜es, I Falca˜o-Pires, IO Gonc¸alves, J Lumini-Oliveira,
I Marques-Aleixo, E dos Passos, S Rocha-Rodrigues, NG Machado, AC Moreira, D
Miranda-Silva, C Moura, AF Leite-Moreira, PJ Oliveira, Torrella JR., A Ascensa˜o, Syn-
ergistic impact of endurance training and intermittent hypobaric hypoxia on cardiac
function and mitochondrial energetic and signaling, International Journal of Cardiology
(2013), doi: 10.1016/j.ijcard.2013.08.001
This is a PDF file of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
Synergistic impact of endurance training and intermittent hypobaric 
hypoxia on cardiac function and mitochondrial energetic and signaling 
 
 
Magalhães J1*, Falcão-Pires I2, Gonçalves IO1, Lumini-Oliveira J1,3, Marques-Aleixo I1, 
dos Passos E1, Rocha-Rodrigues S1, Machado NG4, Moreira AC4, Miranda-Silva D2, 
Moura C2, Leite-Moreira AF2, Oliveira PJ4, Torrella JR5*, Ascensão A1* 
 
 
1Research Centre in Physical Activity, Health and Leisure, Faculty of Sport, University 
of Porto, Portugal 
2Department of Physiology and Cardiothoracic Surgery, Cardiovascular R&D Unit, 
Faculty of Medicine, University of Porto, Portugal 
3Faculty of Health Sciences, University of Fernando Pessoa, Portugal 
4Centre for Neurosciences and Cell Biology, Department of Life Sciences, University of 
Coimbra, Portugal 
5Department of Physiology and Immunology, Faculty of Biology, University of 
Barcelona, Spain 
* Contributed equally 
 
 Corresponding author: 
José Magalhães 
Research Centre in Physical Activity, Health and Leisure 
Faculty of Sport Sciences, University of Porto 
Rua Dr. Plácido Costa, 91, 4200-450 Porto, Portugal 
e-mail: jmaga@fade.up.pt 
 
 
Running head: Endurance training and intermittent hypobaric hypoxia on cardiac 
function 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 2 
Abstract 
Background: Intermittent hypobaric-hypoxia (IHH) and endurance-training (ET) are 
cardioprotective strategies against stress-stimuli. Mitochondrial modulation appears to 
be an important step of the process. This study aimed to analyse whether a 
combination of these approaches provide additive or synergistic effects improving 
heart-mitochondrial and cardiac-function. 
 
Methods: Two-sets of rats were divided into normoxic-sedentary (NS), normoxic-
exercised (NE, 1h/d/5wks treadmill-running), hypoxic-sedentary (HS,6000m,5h/d/5wks) 
and hypoxic-exercised (HE) to study overall cardiac and mitochondrial function. In vitro 
cardiac mitochondrial oxygen consumption and transmembrane potential were 
evaluated. OXPHOS subunits and ANT protein content were semi-quantified by 
Western Blotting. HIF-1α, VEGF, VEGF-R1 VEGF-R2, BNP, SERCA2a and PLB 
expression were measured by qRT-PCR and cardiac function was characterized by 
echocardiography and hemodynamic parameters. 
  
Results: Respiratory control ratio (RCR) increased in NE, HS and HE vs. NS. 
Susceptibility to anoxia/reoxygenation-induced dysfunction decreased in NE, HS and 
HE vs. NS. HS decreased mitochondrial complex-I and -II subunits; however HE 
completely reverted the decreased content in complex-II subunits. ANT increased in 
HE. HE presented normalized ventricular-arterial coupling (Ea), BNP myocardial levels 
and significantly improved myocardial performance as evaluated by increased cardiac 
output and normalization of the Tei index vs. HS. 
 
Conclusion: Data demonstrates that IHH and ET confer cardiac mitochondria with a 
more resistant phenotype although without visible addictive effects at least under basal 
conditions. It is suggested that the combination of both strategies, although not additive, 
result into improved cardiac function. 
 
 
 
Keywords: Physical exercise, altitude, cardioprotection, bioenergetics 
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Introduction 
Several non-pharmacological approaches, including endurance training (ET) and 
intermittent hypobaric hypoxia (IHH) have been considered effective preventive 
strategies against cardiac and mitochondrial dysfunction caused by different stressors 
[1, 2]. Endurance training has been considered an effective trigger for protection 
against distinct cardiac pathophysiological events [3-5]. The activation of several 
signaling pathways and consequent metabolic and redox remodeling has been 
associated with a cardioprotective phenotype. ET-induced myocardial adaptations 
include induction of myocardial heat shock proteins, increased myocardial 
cyclooxygenase-2 activity, elevated endoplasmic reticulum stress proteins, nitric oxide 
production, improved function of sarcolemmal adenosine triphosphate (ATP)-sensitive 
potassium channels and increased myocardial antioxidant capacity [3]. In addition, the 
signaling and mechanical remodeling induced by ET also leads to alterations on 
mitochondrial physiology which contribute to the overall cardioprotective phenotype. 
Furthermore, despite some controversy [6], cardioprotection afforded by chronic 
exercise might also be mediated by activation of mitochondrial ATP-sensitive 
potassium channels (mitoKATP) [7]. 
On the other hand, published data suggest that cardiac tolerance to acute oxygen 
deprivation can also be prevented by previous long-term exposure to IHH associated 
with natural or simulated high altitude conditions. In fact, a significant amount of data [2, 
8] showed that previous IHH decreases myocardial infarction size, reduces the number 
of ventricular arrhythmias, and improves the recovery of cardiac contractile function 
against acute ischemia-reperfusion (I/R) injury. Although the molecular mechanisms 
related with the cardioprotective effect of chronic IHH are not completely understood, a 
selection of putative candidates have been proposed including an increased generation 
of reactive oxygen species (ROS) [9], nitric oxide [10], and the up-regulation of protein 
kinase C-delta [9], which would serve to prime the tissue to better handle later 
deleterious stimuli. In addition, both the activation of the mitoKATP channels [11, 12] 
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and the increased tolerance of heart mitochondria to calcium-induced MPTP opening 
[13] seem to contribute to the cardioprotection provided by IHH against I/R injury. 
Therefore, both the cardioprotective phenotype provided by ET and IHH may share, at 
least in part, some common signaling pathways. Consequently, an important question 
is whether hearts submitted to intermittent hypoxia can be further primed with ET so 
that the protective phenotype is increased.  
Our hypothesis for this work is that IHH exposure plus an ET regimen in an animal 
model act in an additive or synergistic manner to increase the putative protective 
adaptations in the heart, especially at the mitochondrial level. To answer our relevant 
experimental question, male rats were submitted to IHH and ET alone and sequentially 
and hemodynamic measurements before and after volume overload, as well as 
echocardiography were used to assess cardiac function. Moreover, mitochondrial 
bioenergetics and resistance to in vitro anoxia and reoxygenation were also determined. 
 
Methods 
Reagents 
ECL-Plus was purchased from GE Healthcare UK (RPN2132) and PVDF-membrane 
from BIORAD-US (62-0182). OXPHOS cocktail antibodies were purchased from 
Mitosciences/Abcam-US (MS604), anti-SIRT3 antibody from Cell Signaling-US (2627S), 
anti-ANT antibody from Santa Cruz-US (Sc-9299), and secondary antibodies were 
purchased from GE Healthcare-UK (RPN2124) and from Jackson Immunoresearch-US 
(705-035, 111-035-003). Rat VEGF EIA Kit was purchased from R&D systems Europe 
(RRV00). All other chemicals were purchased from Sigma Aldrich (Portugal).  
 
Animal Care and Treatment 
Two sets of forty Wistar male rats (aged 5 weeks, weighting around 190 g at the 
beginning of the experiments) were randomly divided into four groups (n=10 per 
group): normoxic-sendentary (NS), normoxic-exercised (NE), hypoxic-sendentary (HS) 
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and hypoxic-exercised (HE). The first set of animals was used to study in vitro 
mitochondrial function and related molecular biology markers and the second to 
perform echocardiography and in vivo cardiac hemodynamic evaluation. During the 
experimental protocol, all animals were housed in collective cages (two animals per 
cage) and maintained in a room at normal atmosphere (21-22ºC; 50-60% humidity) in 
12 h light/12 h dark cycles, receiving standard food chow (A04-SAFE, Scientific Animal 
Food and Engineering, Augy, France) and water ad libitium. The study was approved 
by the local Institutional Review Board and follows the Guidelines for Care and Use of 
Laboratory Animals in research advised by the Federation of European Laboratory 
Animal Science Associations (FELASA). Several authors are accredited by FELASA to 
perform animal experimentation. 
 
Intermittent Hypobaric Hypoxia (IHH) and Endurance Training (ET) Regimens 
Animals in the hypoxic groups (HS, HE) were submitted to an acclimatization period of 
5 h per day during 7 days in a hypobaric chamber (following the first day of hypoxia 
exposure at 2,500 m, altitude was incremented by 500 m/day until a simulated altitude 
of 6,000 m i.e., 49.3 kPa was reached). After the hypoxic acclimatisation period, the 
animals were exposed to intermittent hypobaric hypoxia during 5 weeks (5 h per day 
i.e., from 7-12 a.m., 5 days per week) at a simulated atmospheric pressure equivalent 
to an altitude of 6000 m [adapted from 14]. The lag phase to reach the established 
simulated altitude and to return to sea level conditions corresponded to 12 min. After 
the hypoxic period, the HE group rested for four hours before initiating the endurance 
treadmill training (from 4-5 p.m.). Animals of the normoxic groups (NS, NE) were 
maintained at an atmospheric pressure of 101.3 kPa (760 mmHg) equivalent to sea 
level throughout the protocol.  
In coordination with the hypoxic regimen schedule, the animals from the exercised 
groups (NE, HE) were adapted to the treadmill running during 7 days (following the first 
two days of exercise at 15 m.min-1, speed was increased by 5 m.min-1 until 25 m.min-1 
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were reached). After the adaptation period, the endurance-trained animals ran 1 h per 
day during 5 weeks at a speed of 25 m.min-1 (0% gradient), whereas the non-exercised 
animals (NS, HS) were placed on a non-moving treadmill to minimize handling and 
environmental stress. All the animals completed the entire training program, hypobaric 
hypoxia exposure or both interventions. 
 
Blood Collection and Heart Harvesting for Mitochondrial Studies 
Twenty-four hours after the last training session, the set of animals used to study in 
vitro mitochondrial function were anaesthetised with ketamine (75 mg.kg-1) and 
xylazine (5 mg.kg-1) and the abdominal cavity was opened to expose the inferior cava 
vein. A blood sample of 2 mL was collected in an EDTA-containing tube for the 
determination of haemoglobin concentration and haematocrit. After fast chest opening, 
rat hearts were rapidly excised, rinsed, carefully dried and weighed.  
 
Isolation of Heart Mitochondria 
Mitochondria were prepared using conventional methods of differential centrifugation 
as described [15]. Mitochondrial and homogenate protein contents were determined by 
the Biuret method calibrated with BSA [16]. All isolation procedures were performed at 
0-4°C. Considering the relatively greater abundance of intermyofibrillar (IMF) (~80%) 
compared with subsarcolemmal (SS) (~20%) mitochondria within the cells, a potentially 
dominant role for the IMF subfraction vs. the SS subfraction when studying 
mitochondrial alterations is expected. 
 
Mitochondrial Oxygen Consumption Assays 
Mitochondrial oxygen consumption was measured polarographically, at 25°C, using a 
Biological Oxygen Monitor System (Hansatech Instruments) and a Clark-type oxygen 
electrode (Hansatech DW 1, Norfolk, UK). Reactions were performed in 0.75 mL 
closed, temperature-controlled and magnetically stirred glass chamber containing 0.5 
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mg of mitochondrial protein in a respiration buffer containing 65 mM KCl, 125 mM 
sucrose, 10 mM Tris, 20 mM EGTA, 2.5 mM KH2PO4, pH 7.4. After 1-min equilibration 
period, mitochondrial respiration was initiated by adding glutamate (10 mM) plus 
malate (5 mM) or succinate (10 mM) plus rotenone (4 mM). State 3 respiration was 
measured after adding 333 nmol ADP; state 4 was considered as the rate of oxygen 
after full ADP phosphorylation. The respiratory control ratio (RCR, state3/state 4) and 
the ADP/O ratio (nmol ADP phosphorylated by natom O consumed), were calculated 
according to Estabrook [17], using 474 natom O.mL-1 as the value for oxygen solubility 
at 25°C in double distilled water.  
To evaluate the mitochondrial response to in vitro anoxia/reoxygenation (A/R), anoxia 
was performed exhausting oxygen in the reaction chamber after stimulating 
mitochondrial respiration with the addition of two ADP pulses in glutamate (10 mM) and 
malate (5 mM) energized mitochondria. Energized cardiac mitochondria were 
stimulated with an initial 333 nmol ADP pulse to obtain pre-anoxia respiratory rates. 
The anaerobic conditions were reached in state 4 through the addition of a second 
ADP pulse (1 mM), with the total period of anoxia set to 1 min. Anoxia was followed by 
4 min of in vitro reoxygenation by exposing the reaction medium containing the 
mitochondrial suspension to open air while stirring the suspension. The polarographic 
oxygraph chamber was then closed and respiratory activities were measured again 
after the addition of another 333 nmol ADP pulse.  
 
Mitochondrial Membrane Potential Measurements 
Mitochondrial transmembrane potential (Δψ) was monitored indirectly based on the 
activity of the lipophilic cation tetraphenylphosphonium (TPP+), followed by a TPP+ 
selective electrode prepared as previously described [18]. Reactions were carried out 
in 1 mL of reaction buffer containing 65 mM KCl, 125 mM sucrose, 10 mM Tris, 20 mM 
EGTA, 2.5 mM KH2PO4, pH 7.4, supplemented with 3 µM TPP
+ and 0.5 mg/mL of 
protein with the temperature maintained at 25°C. For measurements of Δψ with 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 8 
complex I substrates, energization was carried out with 10 mM of glutamate and 5 mM 
of malate and ADP-induced phosphorylation was achieved by adding 444 μM ADP. For 
measurements of Δψ with complex II substrates, 10 mM succinate supplemented with 
4 µM rotenone were added to the medium containing 3 mM TPP+ and mitochondria. 
The lag phase, which reflects the time needed to phosphorylate the added ADP, was 
also measured for both substrates. 
 
Western Blotting Assays 
Protein expression was determined by Western-Blot, for that equal amounts of protein 
(50 μg) were denatured in sample loading buffer and separated by dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS/PAGE), followed by a transference to a 
nitrocellulose membrane (Hybond-ECL, Amersham Biosciences). After blotting, 
membranes were blocked with 5% (w/v) non-fat dried milk or BSA in a Tris-buffered 
saline with Tween 20 (TBST-T). The membranes were then incubated with anti-ANT 
(1:1000 dilution; goat polyclonal, Santa Cruz Biotechnology sc-9299) and anti-Sirt3 
(1:1000 dilution; rabbit monoclonal, Cell Signalling 2627). Primary antibodies were 
diluted in TBS-T containing 1% of non-fat dried milk or BSA for 2 h at room 
temperature (22-25º ). After the incubation period, membranes were washed three 
times and incubated for 2h with horseradish peroxidase-conjugated anti-goat for ANT 
(1:10,000; Jackson ImmunoResearch 705-035-003) or anti-rabbit for SIRT3 (1:10,000; 
Jackson ImmunoResearch 111-035-003). Immunoreactive bands were visualized using 
ECL® chemiluminescence reagents (Amersham Biosciences), according to the 
manufacturer’s instructions, followed by exposure to X-ray films (Sigma Z370398). 
Films were then analysed with Quantity One Software (BioRad Laboratories), and 
resulting absorbance values were expressed as the percentage variation of the NS 
group values.  
The OXPHOS Western blotting kit (Mitosciences) containing a cocktail of monoclonal 
antibodies was used to semiquantify the relative levels of the subunits of the 
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mitochondrial oxidative phosphorylation NDUFB8 20 kDa of complex I, Fe-S 30 kDa-
complex II, core 2 – 47 kDa of complex III and alpha 53 kDa subunit of ATP synthase. 
For detection of OXPHOS subunits, all previous steps were followed with exception of 
the following: after electrophoresis, proteins were electrophoretically transfered to 
polyvinylidene fluoride (Immobilon PVDF Transfer Membranes, Millipore) membranes 
and blocked with 5% (w/v) BSA in a TBST-T solution for 2 h at room temperature. 
Primary antibody against OXPHOS subunits (mouse monoclonal, MitoSciences 
MS604) were diluted in TBS-T (1:1,000 dilution) containing 1% of BSA and incubated 
overnight (4°C). Following antibody incubation and washing, membranes were 
incubated for 2 h at room temperature with an alkaline phosphatase-linked secondary 
antibody (goat anti-mouse; Jackson ImmunoResearch 115-055-174) diluted in TBS-T 
(1:2,500 dilution) containing 0.5% of BSA. The bands corresponding to the target 
proteins were detected and quantified using the ECF system (GE Healthcare) on the 
BioSpectrum Imaging System (Ultra-Violet Products). Equal protein transfer efficiency 
was verified by staining membranes with Ponceau S. 
 
Echocardiography Assessment 
Echocardiographic evaluation was performed immediately before the end of the 
experimental protocol, two days before hemodynamic evaluation, using a 7.5 MHz 
transducer. Animals were anaesthetized with ketamine (75 mg.kg-1) and xylazine (5 
mg.kg-1) and allowed to stabilize for 15 min. All images were acquired in regular sinus 
rhythm, at a sweep speed of 200 mm/sec and stored in the system for off-line analysis 
(EchoPAC work station version 3.2 system, VingMed Ultrasound, GE). The 
assessment by M-mode guided by two-dimensional image performed in the left 
parasternal projection, using the short axis of the ventricles (LV), allowed to evaluate 
LV systolic function. This approach determined the measurement of the interventricular 
septum thickness (LV-IVS, mm), LV internal diameter (LV-ID, mm) and the posterior 
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wall thickness (LV-PW, mm) in diastole (d) and systole (s). Fractional shortening was 
calculated from measurements for the LV-ID in systole and diastole: FS (%)=[(LV-IDd–
LVIDs)/LV-IDd]x100. LV ejection fraction was calculated using the cube method: EF 
(%)=[(LV-IDd3–LVIDs3)/LV-IDd3]x100. The mitral E- and A-wave velocities were 
recorded via pulsed wave Doppler from the left parasternal apical 4-chamber view. 
Longitudinal velocities within the myocardium were recorded with pulsed-Tissue 
Doppler Imaging (TDI) from the apical 4-chamber window. The sample volume was 
placed within a myocardial segment and the spectral recording of velocities within the 
segment obtained, including peak myocardial systolic velocity (Sm, mm.s-1), peak 
myocardial early diastolic velocity (Em, mm.s-1) and peak myocardial late diastolic 
velocity (Am, mm.s-1). As recommended, the sample volume was placed at the junction 
of the ventricular wall and mitral annulus.  
Recordings were made at the interventricular septum and in the LV posterior wall. The 
myocardial performance (Tei) index of the LV was calculated according to the equation 
(a-b)/b, in which the “a” value equals the sum of isovolumic contraction time (IVCT, ms), 
ejection time (ms), and isovolumic relaxation time (IVRT, ms) and the “b” value equals 
the ventricular ejection time. 
 
Cardiac Hemodynamic Measurements 
Instrumentation: rats were anaesthetized by inhalation with a mixture of 4% 
sevoflurane with oxygen, intubated for mechanical ventilation (respiratory frequency 
100 min and weight-adjusted tidal volume; Harvard Small Animal Ventilator - Model 
683) and placed over a heating pad (37ºC). The ventilator setting and level of 
anaesthesia were adjusted to maintain the animal in an anesthetized state without 
spontaneous breathing efforts. The right jugular vein was cannulated for fluid 
administration (pre-warmed 0.9% NaCl solution) to compensate for perioperative fluid 
losses. A median sternotomy was performed to expose the heart and the pericardium 
was widely opened. Pressure-volume (PV) catheters were positioned along the long 
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axes of the left ventricle (LV) and right ventricle (RV) (PVR-1035, 1F, and PVR-1045, 
1F, Millar Instruments, Houston, TX, respectively). The catheter was connected to 
MVP-300 conductance system (Millar Instruments), coupled to PowerLab16/30 
converter (AD Instruments) and a personal computer for data acquisitions. Parameters 
from conductance catheter were recorded at a sampling rate of 1000 Hz in order to 
accurately capture all of the features of the pressure-volume waveforms produced by 
the fast beating rat hearts. Data were stored and analyzed with Millar conductance data 
acquisition and analysis software (PVAN3.5). A flow probe (200-367, Triton Technology, 
San Diego, CA) was positioned around the ascending aorta allowing cardiac output 
(CO) measurement with an ultrasonic flowmeter (Active Redirection Transit Time 
Flowmeter, System 6, Triton Technology, San Diego, CA). After complete 
instrumentation, the animal preparation was allowed to stabilize for 15 min. 
Hemodynamic recordings were made with respiration suspended at the end of 
expiration under steady-state conditions or during preload reductions (vena cava 
occlusions). 
Measured parameters: Heart rate, stroke volume (SV, l), cardiac output (CO, 
mL.min1), ejection-fraction (EF, %), end-diastolic pressure (LV-EDP and RV-EDP, 
mmHg) and end-systolic pressure (LV-ESP and RV-ESP, mmHg) were determined 
from the LV pressure tracings. Effective systemic arterial elastance (EA, mmHg.L
-1), 
as a measure of LV afterload, was calculated dividing LV-ESP by the stroke volume. 
Relaxation rate was estimated with the time constant τ (ms) using the Glantz method. 
The intrinsic myocardial function relatively load-independent parameters LV end-
systolic pressure-volume relation (ESPVR, mmHg.L-1), preload recruitable stroke 
work (PRSW) and end-diastolic pressure-volume relation (EDPVR, mmHg.L-1) were 
determined from pressure-volume loops recorded during transient occlusion of the 
inferior vena cava by external progressive compression of the vessel. In order to 
assess inotropic reserve and evaluate cardiac response to acute stress conditions, 
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aortic occlusions were performed by abrupt narrowing or occlusion of the ascending 
aorta (AA) during the diastole, separating two heartbeats (isovolumic heartbeat). 
Increase in peak systolic pressure induced by AA occlusions was expressed as a 
percentage of peak systolic pressure of corresponding baseline heartbeats. 
Parallel conductance values were obtained by the injection of approximately 20-30 l of 
10% NaCl into the right atrium. At the end of the experiment, the animals were 
sacrificed under anaesthesia and mechanical ventilation to obtain a terminal blood 
draw, and the heart was excised and snap-frozen in liquid nitrogen. 
 
Plasma VEGF Content 
In the set of animals used to study in vivo cardiac function, venous blood samples were 
collected in ethylenediamine-tetra-acetic acid-containing tubes, centrifuged at 5000 
rpm for 15 min at 4ºC and plasma separated and frozen at -80ºC until analysis. 
Endogenous plasma vascular endothelial growth factor (VEGF) was quantified using a 
VEGF EIA Kit (R&D systems Europe, United Kingdom) accordingly to manufacturer’s 
instructions. Absorbance was measured at 450 nm, with the correction wavelength set 
at 570 nm, using an ELISA plate reader (Perkin-Elmer, Wellesley, Massachusetts). A 
standard logarithmic curve was plotted and used to calculate VEGF concentrations in 
the plasma samples. 
 
Quantitative real-time RT-PCR analysis 
Two-step real-time RT-PCR was performed as previously described [19] using samples 
from right and left ventricles. Briefly, after total mRNA extraction using a commercial kit 
(no. 74124; Qiagen), standard curves were obtained for each gene correlating 
(R>0.98) the mRNA quantities in graded dilutions from a randomly selected tissue 
sample with the respective threshold cycles (second derivative maximum method). 
Equal amounts of mRNA from every sample underwent two-step real-time RT-PCR 
experiments for each gene, using SYBR green as marker (no. 204143; Qiagen). 
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GAPDH was used as internal control because its mRNA levels were similar between 
groups. Results are relative to the mean obtained for the NS group (set as arbitrary 
unit) after normalizing for GAPDH. Specific PCR primer pairs for the studied genes 
were: GAPDH: fw 5’- TGG CCT TCC GTG TTC CTA CCC -3’ and rev 5’- CCG CCT 
GCT TCA CCA CCT TCT -3’; type-B natriuretic peptide (BNP) – fw 5’- CAG AGC TGG 
GGA AAG AAG AG -3’ and rev 5’- GGA CCA AGG CCC TAC AAA AGA -3’; VEGF: fw 
5' - GTA CCT CCA CCA TGC CAA GT - 3' and rev 5' - GCA TTA GGG GCA CAC AGG 
AC - 3'; VEGF-receptor 1 (VEGF-R1): fw 5' - CGG CAG ACC AAT ACA ATC CT - 
3'and rev 5'- TGT ATT GAG GTC CGT GGT GA - 3'; VEGF-receptor 2 (VEGF-R2): fw 
5' - ACA GTT CCC AGA GTG GTT GG - 3' and rev 5'- GTC ACT GAC AGA GGC GAT 
GA - 3'; Hypoxia-inducible factor-α (HIF-1α): fw 5' - TCA TAG GCG GTT TCT TGT 
AGC - 3' and rev 5’ - CTA ACA AGC CGG GGG AGG AC - 3'; Sarcoplasmic reticulum 
Ca2+ ATPase (SERCA2a): fw 5' - AAT TCT AAT ACG ACT CAC TAT AGG GAG AAG 
GGG AGG AGA TGA GGT AGC GGA TGA A - 3' and rev 5' - CGA GTT GAA CCT 
TCC CAC AA - 3' and Phospholamban (PLB): fw 5' - AAT TCT AAT ACG ACT CAC 
TAT AGG GAG AAG GGG TGG - 3' and rev 5' - GGC ATC ATG GAA AAA GTC CA - 
3'. 
 
Statistical Analysis 
Means and standard errors of mean were calculated for all variables in each group. 
Two-way ANOVA followed by the Bonferroni post-hoc test was used to compare 
groups. Statistical Package for the Social Sciences (SPSS Inc, version 10.0) was used 
for all analyses. The significance level was set at 5%. 
 
Results 
Characterization of the animals from the different groups 
Animal data from the first and second set of animals (n=80) were pooled together for 
analysis. As seen in Table I, in comparison with NS, significantly lower body mass were 
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observed in NE, HS and HE. Moreover, body mass and femur length/body mass in the 
HE group were even lower that in HS. No differences were found concerning heart 
mass; however heart mass/body mass ratio was higher in NE and HE when compared 
to NS. As expected, hemoglobin concentration and hematocrit were significantly 
elevated in the hypoxic groups (HS and HE) when compared to their normoxic 
counterparts (NS and NE). 
 
*** Insert Table I here *** 
 
Heart mitochondrial bioenergetics 
Table II shows the mitochondrial oxygen consumption endpoints for the different 
experimental groups. Respiration was sustained by using complex I (glutamate/malate) 
and II (succinate). A significant decrease in state 3 respiration with glutamate/malate 
was found in HE when compared to NE. In addition, state 4 respiration with both 
substrates decreased significantly in mitochondria from hypoxic groups (HS and HE) 
compared to their normoxic counterparts. RCR increased in NE, HS and HE 
mitochondria compared to NS when complex I substrates were used. Differences in the 
ADP/O ratio were found in succinate-energized mitochondria from hypoxic groups (HS 
and HE) when compared to their normoxic counterparts (NS and NE). 
Results from mitochondrial membrane potential measurements (Table III) revealed that 
ADP caused a significantly lower membrane depolarization in NE and HE mitochondria 
energized with complex I substrates when compared with NS, the same occurring with 
the repolarization potential. When using complex II substrates, the only difference 
between experimental groups was related with the lag phase. In fact, when the hypoxic 
stimuli and the ET were combined (HE), mitochondria demonstrated a shorter lag 
phase than the sedentary normoxic and hypoxic groups (NS and HS, respectively). 
 
*** Insert Table II here *** 
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*** Insert Table III here *** 
 
In order to analyze whether IHH and ET and the combination of both approaches 
contributed to alter mitochondrial function through the modulation of critical electron 
transport chain complexes, immunoblotts of specific OXPHOS subunits for complex I, II, 
III and V were performed (Figure 1). IHH per se induced a significant decrease in levels 
complex -I and -II subunits as compared to normoxic control group (HS vs. NS). 
Moreover, IHH plus ET regimen (HE) completely reverted the decreased amount of 
complex -I and -II subunits (HE vs. HS). No alterations between experimental groups 
were observed in complex III and V subunits. 
 
*** Insert Figure 1 here *** 
 
In vitro A/R stress is an appropriate strategy to investigate intrinsic mitochondrial 
defenses [15]. In order to find out which experimental group would resist more to A/R, 
oxygen consumption endpoints were measured before and after the deleterious 
stimulus (Table IV). With the exception of ADP/O ratio in all groups and state 4 in HE 
group, A/R affected overall heart mitochondrial bioenergetics. Considering RCR the 
best general measure of mitochondrial function in isolated mitochondria [20], it was of 
notice that both IHH and ET significantly attenuated the decrease in mitochondrial 
function caused by A/R stress (NE, HS and HE vs. NS). However, no further effect was 
observed in the RCR of HE when compared to HS and/or NE groups. 
 
*** Insert Table IV here *** 
 
In order to investigate specific alterations that would suggest differential modulation of 
cardiac content of ANT, a mitochondrial protein involved in the phosphorylated system, 
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immunoblotts were performed (Figure 2). IHH combined with ET (HE) induced a 
significant increase in the content of ANT compared to all other groups.  
Heart mitochondrial SIRT3, which is involved in the regulation of mitochondrial 
metabolism and resistance to oxidative stress [21], was semi-quantified by Western 
Blotting. However, no differences were found between groups regarding this specific 
sirtuin (data not shown). 
 
Assessment of cardiac function and structure  
ET (NE and HE groups) significantly increased left ventricle IVSs (Figure 3A), ejection 
fraction (Figure 3B), maximal aortic outflow (Ao) velocity (Figure 3C) compared to their 
sedentary counterparts (NS and HS), while LV dimensions were maintained (LVDs: 
NS: 3.2±0.2 mm, NE: 3.0±0.3 mm, HS: 3.2±0.4 mm, HE: 3.0±0.2 mm; LVDd: NS: 
7.0±0.1 mm, NE: 6.3±0.4 mm, HS: 6.6±0.3 mm, HE: 6.7±0.2 mm). Time of isovolumic 
relaxation (IVRT) decreased in NE and HE when compared to NS and HS groups 
(Figure 3G). Doppler imaging revealed that ET (NE and HE) increased myocardial 
velocity both during systole, as shown by Sm (Figure 3E) and in diastole, as shown by 
Am (Figure 3F) compared to sedentary animals (NS and HS), while peak myocardial 
early diastolic velocity (Em) did not change significantly (NS: 3.2±0.2 m.s-1, NE: 3.0±0.3 
m.s-1, HS: 3.2±0.4 m.s-1, HE: 3.0±0.2 m.s-1).  
IHH per se increased the ratio between mitral E wave velocity and peak myocardial 
early diastolic velocity (E/Em) (Figure 3D). Moreover, IHH increased the time of 
isovolumic contraction (IVCT) (Figure 3H) but decreased Sm (Figure 3E) and Ao 
(Figure 3C). 
IHH animals submitted to additional ET (HE) significantly showed improved myocardial 
performance as evaluated by Tei index compared to HS (Figure 3I). No alterations 
were found in this parameter between HE and NE. Furthermore, ejection fraction, Sm 
and Am were completely normalized (Figure 3B, E and F). We additionally calculated 
total vascular peripheral resistance (PR) to evaluate whether the hemodynamic 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 17 
assessment could reflect vascular changes. Indeed, there was a trend towards an 
increase of PR in HS (207.1±16.1 mmHg.min.l-1) and a normalization of this value in 
the HE rats (169.0±23.0 mmHg.min.l-1 vs NS: 171.5±11.6 mmHg.min.l-1). 
 
*** Insert Figure 3 here *** 
 
With respect to hemodynamic measurements we observed an increase in stroke 
volume in NE when compared to NS. Moreover, it increased even further in HE. 
Cardiac output rose significantly in HE rats (HE vs. all other groups) (Table V). In the 
right ventricle, IHH prolonged the relaxation time constant-Tau and, as expected, 
increased systolic pressures (Table V). ET did not cause any alteration in these 
parameters. The response of cardiac function to isovolumic contractions in terms of 
ESP and EDP percentage of increase from baseline was also evaluated. However, no 
differences between groups were observed in these conditions. Upon an isovolumic 
contraction, IHH groups showed a trend to develop a higher maximal systolic pressure 
but these values were not significant (p=0.12, Table V). Preload recruitable stroke work 
showed a slight tendency to increase in ET groups (Table V). 
 
*** Insert table V here *** 
 
Vascular endothelial growth factor (VEGF) plasma levels 
IHH significantly increased VEGF plasma levels (NS: 29.6±5.0 pg.mL-1, NE: 21.9±6.9 
pg.mL-1, HS: 49.0±11.7 pg.mL-1, HE: 43.1±4.7 pg.mL-1, p=0.05). However, no further 
increase in plasma VEGF content was found IHH when combined with ET. 
 
Gene expression profile 
As shown in Figure 4, BNP gene expression in the overloaded RV increased in HS 
compared to NS being completely normalized in HE rats. The ratio of SERCA2a/PLB 
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significantly decreased in the LV of both hypoxic groups (HS and HE) compared to 
their normoxic counterparts (NS and NE), but remained unaltered in the RV. Except for 
a significant increase observed in LV VEGF-R1 expression induced by IHH (NS: 
1.00±0.10; NE: 1.29±0.28, HS: 1.42±0.18, HE: 1.73±0.34), disappointingly no other 
alterations were observed in the expression of angiogenesis-related markers such as 
HIF-1α (RV - NS: 1.00±0.08, NE: 1.01±0.14, HS: 1.41±0.47, HE: 1.22±0.22; LV - NS: 
1.00±0.30, NE: 1.49±0.46, HS: 1.25±0.20, HE: 1.84±0.70), VEGF (RV - NS: 1.00±0.09, 
NE: 1.38±0.28, HS: 0.94±0.11, HE: 0.92±0.04; LV - NS: 1.00±0.10, NE: 0.98±0.08, HS: 
0.81±0.09, HE: 0.84±0.12), VEGF-r1 (RV - NS: 1.00±0.12, NE: 1.34±0.10, HS: 
0.97±0.15, HE: 1.17±0.20), and VEGF-r2 (RV - NS: 1.00±0.06, NE: 1.03±0.06, HS: 
0.75±0.17, HE: 0.79±0.11; LV - NS: 1.00±0.09, NE: 0.66±0.14, HS: 1.04±0.17, HE: 
0.83±0.17).  
 
*** Insert Figure 4 here *** 
 
Discussion 
Overview of findings 
Despite some controversy [22], it is generally accepted that chronic intermittent hypoxia 
models that resemble repeated severe and short duration hypoxia/reoxygenation 
cycles, of which obstructive sleep apnea syndrome is an example, induce extreme 
ROS-associated cardiac dysfunction [23, 24]. It is however important to notice that the 
present less severe and longer cycle-based model of IHH and ET are considered non-
pharmacological approaches that positively increase heart tissue tolerance against 
major harmful consequences of cardiac deleterious events, such as ischemia-
reperfusion or drug-induced dysfunction [1, 8] targeting mitochondrial bioenergetics 
and (dys)function [4, 14]. Therefore, the main goal of the present study was to 
ascertain whether IHH exposure plus an ET regimen amplify mitochondrial and cardiac 
stress defenses and improve cardiac function and mitochondrial bioenergetics. Data 
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obtained from in vitro analysis of mitochondrial function revealed that both IHH and ET 
improved per se several endpoints of heart mitochondrial bioenergetics. Also, 
combination of these two cardioprotective strategies translated into further 
improvements of cardiac function evaluated under basal conditions, such as the 
observed increase of cardiac output, systolic volume and normalization of the Tei index. 
As a result of IHH exposure, a tendency for cardiac function improvement under 
afterload, which mimics a cardiac response to acute stress conditions, was also 
observed. 
 
Heart mitochondrial bioenergetics 
Mitochondria are vital components in cellular energetic metabolism and in distinct 
intracellular signaling processes. In fact, mitochondria are involved in a myriad of 
complex signaling cascades, namely some regulating cell death vs. survival [25]. 
Therefore, assessing mitochondrial function is critical to understand the relevance of 
the impact of distinct physiological or pathological stimuli on cells homeostasis [20]. 
The mitochondrial RCR is strongly influenced by almost every functional aspect of 
oxidative phosphorylation and it has been considered the best general measure of 
mitochondrial function in isolated mitochondria [20]. Under basal conditions, with 
mitochondria energized with substrates for complex I, the higher RCR found in all 
groups compared to NS group suggest that mitochondria from IHH, ET and combined 
regimens improved their coupling between respiration and ATP synthesis (Table II). 
Results regarding ET are consistent with previous data from our group and others [26] 
and reinforce the idea that this non-pharmacological intervention positively modulate 
cardiac mitochondria to a higher level of metabolic coupling. On the other hand, Zhu et 
al. [14] did not find any alteration in basal heart mitochondrial RCR caused by IHH 
though when supplemental calcium was added to the medium a significant lower 
uncoupling of the respiratory control was observed in the hypoxic groups. In 
accordance, after submitting mitochondria to an in vitro stress test of A/R, we found 
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that RCR was significantly less affected in the hypoxic and/or trained than in the 
normoxic sedentary animals (Table IV). Taking together, data suggest that pre-
condition interventions through IHH and/or ET improved cardiac mitochondrial function 
at baseline and also prevented stress-induced alterations; however an additional 
improvement or protection was not afforded by the combination of both stimuli. 
Considering that absolute respiration rate can give additional useful insights into the 
mechanism of mitochondrial (dys)function, we also analyzed respiration rates during 
state 3 and state 4. RCR encapsulates the main function of mitochondria, i.e., their 
ability to idle at a low rate yet respond to ADP by producing ATP at a high rate [20]; 
however basal (state 4) and phosphorylating (state 3) respiratory rates revealed that 
IHH and ET seem to influence the increased RCR by distinct bioenergetics 
mechanisms. IHH influenced RCR through a significant reduction in state 4, which can 
be explained by a decreasing inner membrane leakage of protons. ET per se (NE vs. 
NS) altered state 3 improving the ability of mitochondria to produce ATP at a higher 
rate as previously reported by our group [15, 21, 26, 27].  
In line with data previously demonstrated by others [28, 29], IHH induced a significant 
global decrease of the OXPHOS subunits with the particular contribution of complex I 
and II (Figure 1). However, in contrast, an increase in the activity of OXPHOS 
complexes I and III was found by Zaobornyj et al. [30] in heart mitochondria of rats 
adapted to long-lasting high-altitude hypoxia (4,340 m, 84 days). Interestingly, our 
study also showed for the first time, that ET combined with IHH (HE) was able to 
completely revert the decrease observed in OXPHOS subunit complex I and II in the 
HS group. Considering that the decreased content of an electron transport chain 
component subunit could not apparently be interpreted as a beneficial mitochondrial 
alteration in the context of cardioprotection, some have suggested that this down-
regulation via PKC-δ may contribute to cardioprotection through the stimulation of 
autophagy, with consequent elimination of damaged mitochondria when a decrease in 
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OXPHOS complex occurs [29]. Further work is needed in order to better clarify this 
topic. 
Although IHH and ET per se did not modify ANT content (NE and HS vs. NS), the 
combination of both cardioprotective strategies induced a significant increase in the 
protein content (HE vs. all other groups) (Figure 2). The important role of ANT in 
mitochondrial bioenergetics as ADP/ATP nucleotide translocator may also contribute to 
the protective phenotype observed in some functional endpoints in HE group. 
We also measured SIRT3 in the cardiac tissue. SIRT3 is emerging as key regulator of 
many cellular functions including metabolism, cell growth, apoptosis, and genetic 
control of ageing [21]. In the heart, SIRT3 has been found to block development of 
cardiac hypertrophy and protect cardiomyocytes from oxidative stress-mediated cell 
death. Moreover, evidence for SIRT3-dependent regulation of global mitochondrial 
function was reported [31]. In particular, it was proposed that the absence of SIRT3 
resulted in a marked alteration of basal in vivo ATP levels and that SIRT3 can 
reversibly bind to and regulate the acetylation and activity of Complex I of the electron-
transport chain. However, in contrast with data revealing increases in the expression of 
rat skeletal muscle SIRT3 (particularly in the oxidative soleus muscle) after 6 weeks of 
voluntary wheel running [32], we were unable to detect any alteration in the content of 
these proteins in heart mitochondria from ET rats. Moreover, IHH protocol was also 
ineffective regarding the stimulation of the SIRT3 expression. 
 
Cardiac function 
As previously described, cardiac pre-conditioning induced by IHH and ET has been 
associated with several mechanisms including attenuated infarct size, myocardial 
fibrosis and apoptosis, diminished ROS release, preservation of calcium homeostasis, 
modulation of mitoKATP channels, increased vascularization as well as anti-arrhythmic 
and antioxidant capacity [1, 3]. However, intrinsic cardiac function using pressure-
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volume hemodynamics after pre-conditioning IHH when combined with another well-
known protective strategy such as ET was yet never addressed. 
To understand the concomitant expression of the molecular adaptations perpetrated by 
IHH and/or ET pre-conditioning regimens in the overall cardiac tissue function and also 
to ascertain whether mitochondrial-related alterations translate into simultaneous 
functional phenotypes, in vivo hemodynamic measurements, as well as 
echocardiographic analysis were performed. In line with data previously discussed at 
molecular level, pre-exposure to IHH combined with ET improved myocardial function. 
A notable and hitherto unreported finding is the fact that HE rats displayed an 
enhanced myocardial performance as demonstrated by Tei index normalization and an 
increase in cardiac output, and stroke volume while arterial elastance decreased 
suggesting that significant vascular alterations may be occurring simultaneously. 
Indeed, the increase in cardiac output without a raise in ESP suggests that the 
mechanical performance of the heart in the HE group might be improved. Furthermore, 
hypoxic rats presented increased levels of plasma VEGF, which suggests increased 
angiogenesis. The Tei index has proved to be a reliable method for the evaluation of 
LV systolic and diastolic performance, being independent from heart rate, age and, 
importantly, blood pressure [34]. More important is the fact that the Tei index presents 
the advantage to evaluate myocardial function independently of the vascular effects 
that IHH and/or ET may induce.  
Considering the relevance of measuring cardiac function under peak stress conditions, 
sudden afterload elevations, more precisely, isovolumic contractions induced by 
transient ascending aortic occlusions (table V) were therefore performed to assess 
inotropic reserve and to evaluate cardiac response to acute stress conditions. During 
this assessment, HS and HE (but not NE) animals showed a small tendency to an 
increased inotropic response, possibly highlighting the pre-conditioning value of IHH 
under stressful conditions imposed by pathological stimuli. Moreover, at the end of 
baseline cardiac function assessment, we also performed volume overload of 
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approximately 30% of circulating volume. These results were similar between groups 
(data not shown). 
Despite our effort to echocardiographically and hemodynamically analyze the pre-
conditioning influence of IHH, ET and the synergistic effect of both interventions on 
cardiac function under baseline and acute stress conditions, we cannot rule out that a 
final ischemia-reperfusion protocol would uncover stronger cardiac functional 
differences between groups. Further studies are needed to address this relevant issue. 
 
Conclusions 
Our data indicated that both IHH and ET positively modulate heart mitochondria under 
basal conditions and that the combination of the two strategies may not afford addictive 
protection. Our data suggests that the alteration of mitochondrial capacity resulting 
from these IHH and ET are associated with a more resistant basal phenotype. 
Moreover, the observed mitochondrial benefits seem to translate into overall cardiac 
function such as increased cardiac output and normalization of the Tei index. Further 
studies are in fact needed in order to mechanistically understand whether the 
combination of these strategies afford cardioprotection against cardiac deleterious 
stimuli or pathophysiological conditions to the heart such as ischemia-reperfusion, 
hyperglycemia, hypercholesterolemia, and drug-induced dysfunction. 
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Figure legends 
 
Figure 1. Effects of IHH and/or ET on heart mitochondrial electron transport chain complex 
subunits Complex I NDUFB8 (20 kDa, A), Complex II Fe-S (30 kDa, B), Complex III core 2 
(47 kDa, C) and ATP synthase alpha 53 kDa subunit (D). Typical immunoblotts of the 
respective proteins are presented (lower panel). Experiments were performed for an 
n=6/group. Control for protein loading was confirmed by Ponceau-S staining. * vs. control 
NS (p<0.05). Data are mean ± SEM.  
 
Figure 2. Effects of IHH and/or ET on heart mitochondrial ANT. Typical immunoblot of the 
protein is presented (lower panel). Experiments were performed for an n=6/group. Control 
for protein loading was confirmed by Ponceau-S staining. * vs. control NS (p<0.05). Data 
are mean ± SEM 
 
Figure 3: Echocardiographic evaluation of the left ventricle performed 2 days before final 
hemodynamic instrumentation. Experiments were performed for an n=10/group. A) 
Interventricular septum thickness in systole (IVSs, mm); B) Ejection fraction (%); C) 
Maximal aortic outflow velocity (Ao, m.s-1); D) Ratio between mitral E wave velocity and 
peak myocardial early diastolic velocity (E/Em); E) Peak myocardial systolic velocity (Sm, 
m.s-1); F) Peak myocardial late diastolic velocity (Am, m.s-1); G) Isovolumic relaxation time 
(IVRT, ms); H) Isovolumic contraction time (IVCT, ms); I) Tei index. ET significantly 
increased IVSs (p=0.04), EF (p=0.03), Sm (p=0.02), Am (p=0.03) and Ao (p=0.04). IHH 
increased E/Em (p=0.01, Figure 1G) and IVCT (p=0.001) while decreased Sm (p=0.02) and 
Ao (p=0.02). ET in hypoxic conditions normalized the Tei index. * vs. NS; $ vs. NE; # vs. HS 
(p<0.05). Data are mean ± SEM. 
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Figure 4: Expression of type-B natriuretic peptide (BNP) and ratio between sarcoplasmic 
reticulum Ca2+ ATPase (SERCA2a) and phospholamban (PLB) in right (RV, A and C, 
respectively) and left ventricle (LV, B and D, respectively) collected after hemodynamic 
instrumentation. BNP results are normalized for GAPDH and expressed in arbitrary units 
(AU). Experiments were performed for an n=10/group. * vs. NS; $ vs. NE; # vs. HS (p<0.05). 
Data are mean ± SEM. 
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Table I. Animal data and mitochondrial isolation yield 
 
 NS NE HS HE 
Body mass (g) 393.1 ± 6.2 342.6 ± 7.1* 359.2 ± 8.2* 316.0 ± 9.1*
,#
 
Heart mass (g) 0.84 ± 0.05
 
0.85 ± 0.04 0.88 ± 0.07 0.88 ± 0.02
 
Heart mass/body mass (mg.g
-1
) 2.20 ± 0.10
 
2.44 ± 0.13* 2.47 ± 0.20 2.75 ± 0.11*
 
Femur length/body mass (mm.g
-1
) 0.093 ± 0.001
 
0.104 ± 0.002* 0.112 ± 0.002*
 
0.094 ± 0.004
# 
Hemoglobin  (g.dl
-1
) 14.30 ± 0.30 14.37 ± 0.15 21.03 ± 0.72* 18.91 ± 0.10*
,$
 
Hematocrit (%) 43.24 ± 1.27 43.17 ± 0.38 64.75 ± 3.31* 58.26 ± 0.36*
,$
 
Heart mitochondrial isolation yield 
(mg.g
-1
) 
19.6 ± 2.0 23.4 ± 3.5 21.0 ± 0.8 21.7 ± 1.7 
 
Data are mean ± SEM. NS, normoxic sedentary; NE, normoxic exercised; HS, hypoxic sedentary; HE, 
hypoxic exercised. * vs. NS, 
#
 vs. HS, 
$
 vs. NE, p<0.05 
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Table II. Effect of IHH and/or ET on state 3 and state 4 respiratory rates and on 
RCR and ADP/O ratios of rat heart mitochondria energized with substrates for 
complex I and for complex II  
 
 State 3 
nmolatmsO/mg prot/min 
State 4 
nmolatmsO/mg prot/min 
RCR ADP/O 
Complex I (glutamate/malate) 
NS 451.8  28.2 70.6  2.2 6.4  0.3 2.6 ± 0.2 
NE 507.5  23.1 68.3  1.9 7.4  0.4* 3.4 ± 0.3 
HS 429.0  34.2 56.0  3.8* 7.8  0.1* 3.6 ± 0.3 
HE 403.8  14.2$
 
53.3  2.6*
,$
 7.6  0.3* 3.4 ± 0.5 
 
Complex II (succinate) 
NS 568.1  58.2 213.1  10.2 2.6  0.2 2.0 ± 0.2 
NE 521.2  86.0 189.0  15.1 2.7  0.3 1.8 ± 0.2 
HS 524.9  71.9 173.2  9.8* 3.1  0.4 3.0 ± 0.1* 
HE 591.1  75.8 175.2  8.8*,$ 3.3  0.3 3.0 ± 0.3*,$ 
 
Data are mean ± SEM for heart mitochondria (0.5 mg/mL protein) isolated from all 
experimental groups and obtained from 10 independent isolations from each group. 
Oxidative phosphorylation was measured polarographically at 25ºC in a total volume of 0.75 
mL. Respiration medium and other experimental details are provided in the materials and 
methods section. RCR – respiratory control ratio (state 3/state 4); ADP/O - number of nmol 
ADP phosphorylated by natoms O consumed; NS, normoxic sedentary; NE, normoxic 
exercised; HS, hypoxic sedentary; HE, hypoxic exercised; * vs. NS; 
$
 vs. NE, p<0.05 
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Table III. Effect of IHH and/or ET on electric transmembrane potential (ΔΨ) 
fluctuations of rat heart mitochondria energized with complex I and II substrates 
 
 Initial Polarization ADP 
Depolarization 
    
Repolarization 
                       
Lag Phase 
 ΔΨ (-mV) s 
 
Complex I (glutamate plus malate) 
NS 219.5  1.9 185.0  2.1 216.9  1.7 48.8  2.7 
NE 214.  1.8 175.9  2.9* 209.1  1.3* 49.2  6.4 
HS 218.9  2.8 178.5  3.1 214.5  2.4 50.7  5.7 
HE 215.9  2.3 176.2  1.7* 210.4  1.9* 53.1  6.5 
 
Complex II (succinate) 
NS 223.6  2.7 182.1  2.3 221.7  2.2 51.4  1.6 
NE 219.4  5.2 181.4  1.7 216.9  3.2 43.8  2.7 
HS 222.0  1.7 178.4  2.5 221.0  1.8 48.8  2.9 
HE 218.0  2.4 178.6  3.9 218.2  2.9 37.2  6.2*,# 
 
Data are means ± SEM for heart mitochondria (0.5 mg/mL protein) isolated from all 
experimental groups and obtained from 10 independent isolations. Table shows the values for 
mitochondrial transmembrane potential developed with glutamate (10 mM) plus malate (5 mM) 
and with sucinate (2 mM) plus rotenone (4 M), the decrease in transmembrane potential after 
ADP addition (depolarization), the repolarization value after ADP phosphorylation, and the lag 
phase that precedes repolarization. Mitochondrial transmembrane potential was measured 
using a TPP
+
-selective electrode at 25ºC in a total volume of 1 mL. Reaction medium and 
other experimental details are provided in the methods section; NS, normoxic sedentary; NE, 
normoxic exercised; HS, hypoxic sedentary; HE, hypoxic exercised; * vs. NS; 
#
 vs. HS, p<0.05 
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Table IV. Effect of anoxia-reoxigenation (A/R) on the respiratory rates of heart mitochondria energized with substrates for complex I 
 
 
 State 3 
nmolatmsO/mg prot/min 
State 4 
nmolatmsO/mg prot/min 
RCR ADP/O 
 Before A/R After A/R Before A/R After A/R Before A/R After A/R Before A/R After A/R 
NS 451.8  28.2 156.7  4.8a (189%) 70.6  2.2 91.4  2.6 a (23%) 6.4  0.3 1.7  0.1 a (276%) 2.6 ± 0.2 2.5 ± 0.2 (4%) 
NE 507.5  23.1 176.9  13.9a (186%) 68.3  1.9 78.3  1.9* a (13%) 7.4  0.4* 2.3  0.2* a (221%) 3.4 ± 0.3 2.9 ± 0.5 (17%) 
HS 428.9  34.2 194.6  5.3* a (121%) 56.0  3.8* 72.3  7.1 a (22%) 7.8  0.1* 2.7  0.1* a (188%) 3.6 ± 0.3 3.1 ± 0.4 (16%) 
HE 403.8  14.2$ 147.1  8.5#,$ a (174%) 53.3  2.6$ 57.9  3.3*,#,$ (9%) 7.6  0.3* 2.6  0.1* a (192%) 3.4 ± 0.5 3.1 ± 0.5 (10%) 
 
Data are meanSEM for heart mitochondria (0.5 mg/mL protein) isolated from all experimental groups and obtained from 10 independent experiments. 
Oxidative phosphorylation was measured polarographically at 25ºC in a total volume of 0.75 mL. Respiration medium and other experimental details are 
provided in methods. RCR – respiratory control ratio (state 3/state 4); ADP/O - number of nmol ADP phosphorylated by nanomoles O2 consumed. NS, 
normoxic sedentary; NE, normoxic exercised; HS, hypoxic sedentary; HE, hypoxic exercised. * vs. NS, 
#
 vs. HS,
 $
 vs. NE, 
a
 vs. Before A/R, p<0.05, (% -
percentage of variation before vs. after A/R). 
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Table V. Effect of IHH and/or ET on hemodynamic parameters 
 NS NE HS HE 
Baseline     
HR (bpm) 330±28 330±67 354±22 310±25 
CO (mL.min
-1
) 46.2±4.5 49.3±8.0 46.7±2.7 62.3±2.9*$# 
SV (µl) 143.0±14.1 160.2±9.6* 131.7±11.8 172.4±26.7# 
PR (mmHg.min.l
-1
) 171.5±11.6 185.1±41.6 207.1±16.2 169.0±23.0 
RV Function     
ESP (mmHg) 25.0±1.1 25.6±2.0 32.8±1.3* 31.5±3.8$ 
EDP (mmHg) 3.3±0.5 3.5±0.2 3.8±0.3 4.1±0.5 
dP/dtmax (mmHg.s
-1
) 2049±151 2313±225 2370±227 2413±470 
dP/dtmin (mmHg.s
-1
) -1336±141 -1634±396 -1464±70 -1335±304 
Tau (ms) 14.4±3.4 11.0±3.7 25.0±6.5* 22.3±5.6$ 
     
LV Function     
ESP (mmHg) 95.1±9.9 116.9±17.7 112.6±5.8 107.2±15.4 
EDP (mmHg) 5.2±0.8 5.9±1.7 4.5±0.7 5.0±0.6 
dP/dtmax (mmHg.s
-1
) 7279±1084 10053±1351 8400±854 9347±2010 
dP/dtmin (mmHg.s
-1
) -6418±1500 -6876±629 -6584±500 -5526±1199 
Tau (ms) 15.3±2.1 13.6±0.6 15.6±1.1 16.7±1.1 
EA (mmHg.µl
-1
) 0.65±0.10 0.56±0.12 0.81±0.07 0.56±0.01# 
     
IVC Occlusions     
LV-ESPVR (mmHg.µl
-1
) 32.2±10.4 32.6±15.7 41.1±19.2 39.7±25.8 
LV-PRSW (mmHg) 52.3±13.8 96.5±26.5 52.1±10.8 76.0±17.3 
LV-EDPVR (mmHg.µl
-1
) 0.06±0.01 0.10±0.03 0.17±0.09 0.13±0.07 
     
AA Occlusions     
Isovolumic contraction 
(∆% baseline) 
151.3±20.9 142.5±34.3 184.7±44.4 197.4±33.1 
 
Data are mean ± SEM. AA, ascending aorta; CO, cardiac output; dP/dtmax, maximal rate of pressure 
rise; dP/dtmin, maximal rate of pressure decline EA, arterial elastance; EF, ejection fraction; HR, heart 
rate; IVC, inferior vena cava; EDP, end-diastolic pressure; ESP, end-systolic or maximum pressure; 
EDPVR, end-diastolic pressure-volume relationship slope; ESPVR, end-systolic pressure-volume 
relationship slope; LV, left ventricle; RV, right ventricle; PR, vascular peripheral resistance; PRSW, 
preload recruitable stroke work slope and Tau, time-constant of isovolumic relaxation calculated by 
glantz method. * p<0.05 vs. NS; $ p<0.05 vs. NE; # p<0.05 vs. HS.  
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Figure 1 
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Figure 2 
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Figure 3 
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Figure 4 
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